Tag: Human Papillomavirus (HPV)
One Dose of HPV Vaccine May Be Sufficient in Certain Situations
One dose compared with two or three doses in preventing cervical precancer in high-coverage settings
Targeted Interventions Raise HPV Vaccine Acceptance in Women
Educational videos produced the highest rate of acceptability and knowledge
Review: HPV Vaccination Program Has Considerable Impact
Prevalence of HPV 16 and 18 decreased; anogenital wart diagnoses down in girls, women, boys, men
ACIP: Men as Old as 26 Should Get HPV Vaccine
Panel also no longer advises that healthy Americans ≥65 routinely receive Prevnar 13 vaccination
HPV16 Antibodies Can Develop Long Before Throat Cancer Diagnosis
HPV16-E6 seropositivity increases with shorter lead time, reaching 38.9 percent for <10 years
Mouth Rinse for HPV DNA May Be Biomarker in Head, Neck Cancer
Persistent detection of tumor-type HPV DNA during treatment tied to increased risk for recurrence, death
CDC: Recent Decline Seen in High-Grade Cervical Lesions
Vast majority of cervical precancer cases attributable to HPV types targeted by 9-valent HPV vaccine
Histologic Clearance of CIN2/3 Seen With HPV Therapeutic Vaccine
In phase II trial, rate of complete resolution of CIN2/3 significantly higher for vaccine versus placebo group
Drop Seen in Preinvasive Cervical Disease With HPV Vaccination
Vaccine effectiveness increased for immunization at younger age
AACR: HPV Vax Low for Adults at High Risk for HIV Infection
Age, sex, sexual orientation differences in HPV vaccination rates were statistically significant
